Financial reports
10-Q
2019 Q3
Quarterly report
31 Oct 19
10-Q
2019 Q2
Quarterly report
30 Jul 19
10-Q
2019 Q1
Quarterly report
25 Apr 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
25 Oct 18
10-Q
2018 Q2
Quarterly report
26 Jul 18
10-Q
2018 Q1
Quarterly report
4 May 18
10-K
2017 FY
Annual report
7 Feb 18
10-Q
2017 Q3
Quarterly report
26 Oct 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
22 Nov 19
8-K
CELGENE Announces plans to transfer listing of Celgene’s Contingent value rights following Closing of Acquisition by Bristol-Myers Squibb
20 Nov 19
8-K
Celgene Reports Third Quarter 2019
31 Oct 19
8-K
Entry into a Material Definitive Agreement
26 Aug 19
8-K
Celgene Reports Second Quarter 2019
30 Jul 19
8-K
Celgene Reports First Quarter 2019
25 Apr 19
8-K
Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb
12 Apr 19
8-K
Other Events
4 Apr 19
8-K
Celgene Settles U.s. Revlimid®patent Litigation with Alvogen
29 Mar 19
8-K
Other Events
26 Mar 19
Registration and prospectus
15-12B
Securities registration termination
13 Dec 19
S-4 POS
Post-effective amendment to a S-4EF registration statement
9 Dec 19
S-4 POS
Post-effective amendment to a S-4EF registration statement
9 Dec 19
S-4 POS
Post-effective amendment to a S-4EF registration statement
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Dec 19
Proxies
DEFM14A
Proxy related to merger
22 Feb 19
DEFA14A
Additional proxy soliciting materials
23 May 18
DEFA14A
Additional proxy soliciting materials
18 May 18
DEFA14A
Additional proxy soliciting materials
30 Apr 18
DEF 14A
Definitive proxy
30 Apr 18
DEFA14A
Additional proxy soliciting materials
26 May 17
DEFA14A
Additional proxy soliciting materials
27 Apr 17
DEF 14A
Definitive proxy
27 Apr 17
DEFA14A
Additional proxy soliciting materials
2 Jun 16
DEFA14A
Additional proxy soliciting materials
10 May 16
Other
CORRESP
Correspondence with SEC
14 Feb 18
NO ACT
No action letter
30 Mar 17
NO ACT
No action letter
22 Feb 17
UPLOAD
Letter from SEC
17 Oct 16
CORRESP
Correspondence with SEC
4 Oct 16
UPLOAD
Letter from SEC
19 Sep 16
CORRESP
Correspondence with SEC
16 Aug 16
CORRESP
Correspondence with SEC
21 Jul 16
UPLOAD
Letter from SEC
19 Jul 16
CORRESP
Correspondence with SEC
21 Jun 16